Curis
CRIS
$14.47
Share price
-0.34%
Change (1 day)
1,731.65%
Change (1 year)
Categories
Curis (CRIS) - Net assets
Net assets on the balance sheet as of December 2023 : $19.67 M
According to Curis's latest financial reports the company has $19.67 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Curis - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $19.67 M | -57.75% |
| 2022-12-31 | $46.55 M | -48.68% |
| 2021-12-31 | $90.7 M | -30.58% |
| 2020-12-31 | $0.13 B | -485.33% |
| 2019-12-31 | $-33.92 M | 654.25% |
| 2018-12-31 | $-4.5 M | -118.74% |
| 2017-12-31 | $23.99 M | -18.02% |
| 2016-12-31 | $29.26 M | -54.63% |
| 2015-12-31 | $64.51 M | 116.6% |
| 2014-12-31 | $29.78 M | -34.07% |
| 2013-12-31 | $45.17 M | 31.83% |
| 2012-12-31 | $34.26 M | -14.06% |
| 2011-12-31 | $39.87 M | -12.39% |
| 2010-12-31 | $45.51 M | 37.71% |
| 2009-12-31 | $33.05 M | -11.21% |
| 2008-12-31 | $37.22 M | -20.54% |
| 2007-12-31 | $46.84 M | 30.5% |
| 2006-12-31 | $35.89 M | -5.53% |
| 2005-12-31 | $37.99 M | -21.35% |
| 2004-12-31 | $48.31 M | 24.31% |
| 2003-12-31 | $38.86 M | 109.6% |
| 2002-12-31 | $18.54 M | -81.64% |
| 2001-12-31 | $0.10 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $89.28 B | 453,829.84% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $29.48 B | 149,798.32% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $26.8 M | 36.27% | 🇺🇸 USA |
 Exelixis EXEL | $2.26 B | 11,409.46% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.42 B | 2,081.86% | 🇺🇸 USA |
 Cel-Sci
CVM | $12.65 M | -35.69% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.64 B | 3,200.97% | 🇺🇸 USA |